Alcohol caused 3.3 million deaths in 2012 and its burden is not only limited to mortality; large economical and societal problems result from the harmful consumption of alcohol.
Alcoholic liver disease (ALD) consists of a spectrum of pathologies, ranging from alcoholic fatty liver, alcoholic steatohepatitis, cirrhosis and hepatocellular carcinoma. 90 to 100% of heavy drinkers suffer from alcoholic fatty liver while approximatively 10% develop alcoholic cirrhosis.
Genetic factors, metabolic syndrome, nutritional factors, dysbiosis as well as viral hepatitis infection contribute to the hazardous effect of alcohol and influence the progression of ALD.
The efficacy of the existing ALD treatments requires the maintenance of total alcohol abstinence and no optimal treatment of patients with ALD is available.
Recently, multidisciplinary approaches allaying hepatologists and mental health professionals offering personalized management and pharmacological therapy have shown promising results.
Alcohol and the liver at ILC
Submit your research
for valuable exposure at the ILC 2017
Abstract submission categories include alcoholic liver disease
- Clinical aspects
- Experimental and pathophysiology
Abstract submission deadline: 22 November 2016!
AWARH 2016 will be held from 21-25 November 2016.
This year’s theme is: Alcohol: A Cross-Border Health Determinant
SAVE THE DATE, AVMSD: What about our kids?
The Audiovisual Media Services Directive
offers a once in a decade opportunity to protect children from commercial communications on alcohol and unhealthy foods.
On 1 December
, join experts
from a wide range of backgrounds to discuss the effects of advertising on children’s behaviors, tools to reduce child exposure to commercial communications for unhealthy food and alcohol and the effectiveness of self-regulatory schemes.
The EASL Office